LFA-1 STRUCTURE, FUNCTION, AND INSIDE-OUT ACTIVATION
====================================================

Twenty-four different integrins are expressed in humans, each composed of non-covalently associated α and β chains ([@B40]). Integrins have large extracellular domains, single-pass transmembrane segments, and short intracellular tails. Lacking enzymatic activity, the short integrin cytoplasmic domains serve as scaffolds for signaling and structural proteins that allow integrins to be a conduit of bidirectional communication between the cytoplasm and extracellular ligands ([@B52]; [@B69]) \[**Box [1](#BX1){ref-type="boxed-text"}**\]. The integrin ligand recognition site spans the β subunit inserted-like (βI) domain and α subunit β-propeller domain or, for about half of the integrin family, resides entirely within the α subunit I (αI) domain ([@B57]; [@B59]). All β~2~ integrins, including LFA-1 (α~L~β~2~ or CD11a/CD18) \[**Box [2](#BX2){ref-type="boxed-text"}**\], contain this extra αI domain within the headpiece. The structural features of the various domains of LFA-1 have been reviewed in great detail elsewhere ([@B59]).

###### Box 1 "Inside-out" and "outside-in" signaling.

Inside-out signaling refers to a process by which a cellular stimulus, for example, a chemokine binding to its receptor, leads to integrin activation by intracellular signaling pathways. Inside-out signaling leads to vast conformational changes in integrins, but not directly to clustering (redistribution of integrin heterodimers in the plane of the plasma membrane). By contrast, outside-in activation refers to integrin activation induced by ligand binding. Although the terminology is often confused, outside-in *signaling*, distinct from outside-in *activation*, refers to a process whereby the cell receives signals from the extracellular environment through integrins that have already been activated and are now bound to immobilized ligands on another cell or in the extracellular matrix. Adhesion strengthening, or stabilization, is a process following integrin activation and initial ligand binding. Adhesion strengthening most likely involves integrin clustering and is required to keep arrested leukocytes from being washed away.

###### Box 2 β integrin family.

The β~2~ subfamily of integrins comprises four heterodimers. α~L~β~2~ (LFA-1, CD11a/CD18) is expressed on all leukocytes; α~M~β~2~ (Mac-1, CD11b/CD18) is expressed on granulocytes, monocytes, macrophages, and subsets of activated lymphocytes; α~X~β~2~ (P150,95, CD11c/CD18) is expressed on dendritic cells, macrophages, and small subsets of blood monocytes; and α~D~β~2~ (CD11d/CD18) is expressed on tissue-specific subsets of macrophages.

The macromolecular structure of integrins is coupled to the accessibility of the ligand-binding pocket and to its ligand-binding affinity. Therefore, the regulation of integrin conformation is critical for their adhesive and signaling function ([@B59]). Studies employing crystallography ([@B84]), nuclear magnetic resonance ([@B39]; [@B53]), electron microscopy ([@B70]), and molecular dynamics simulation ([@B41]) have suggested that LFA-1 can assume at least three distinct conformational states (**Figure [1](#F1){ref-type="fig"}**). In its inactive state, the LFA-1 extracellular domain has a bent structure shaped like an inverted V ([@B70]) with the low affinity headpiece closely approaching the plasma membrane ([@B50]; [@B70]), similar to what has been shown for other integrins ([@B99]; [@B20]; [@B109]; [@B98]). The inactive state is also characterized by inter-domain contacts between the N-terminal headpiece and membrane-proximal lower legs, between the lower legs of the α and β chains, and between the α and β transmembrane domains (TMDs; [@B92]; [@B56]; [@B60]; [@B72]; [@B70]). Based primarily on mutational studies, it is thought that close association of TMDs stabilizes the inactive state and disruption of this association leads to integrin activation ([@B38]; [@B58]; [@B95]; [@B60]).

![**LFA-1 conformations.** Integrin function is structurally regulated and three distinct conformations have been demonstrated. In its low affinity state (left), LFA-1 is compact with a sharp bend at the "genu" and headpiece closely approaching the plasma membrane. Extended conformations (middle) differ in the orientation of their hybrid domain (purple), with swingout of this domain representing a conversion from intermediate to high affinity state (right). Data suggest that the extended/closed conformation (middle) can have either a low or intermediate affinity αI domain.](fimmu-03-00157-g001){#F1}

In contrast to the compact structure of inactive LFA-1, active LFA-1 conformations exhibit an extended extracellular domain with the ligand-binding headpiece situated more than 20 nm above the membrane ([@B70]). Extended structures of LFA-1 (**Figure [1](#F1){ref-type="fig"}**) differ in the conformation of the headpiece and αI domain, the angle between the βI domain and hybrid domain into which the βI is inserted, and the distance between the α~L~ and β~2~ TMDs in the plane of the plasma membrane. The extended ectodomain with a closed headpiece has also been termed the "intermediate affinity state" integrin ([@B59]). It is thought that the spatial orientation of the headpiece alone in the extended intermediate affinity structure may account for enhanced recognition of ligands, as steric hinderance may prevent large, immobilized ligands from accessing the αI domain in the bent, inactive LFA-1 conformer. This idea is supported by data showing that the isolated LFA-1 αI domain alone, in its basal state, can mediate transient interactions with intercellular adhesion molecule-1 (ICAM-1) that result in a rolling phenotype ([@B46]; [@B29]), whereas the full-length LFA-1 molecule does not support interaction under flow conditions ([@B77]). However, in a series of disulfide-stabilized crystal structures of the α~L~ I domain, distinct conformations with low, intermediate, and high affinity were identified, where the transition from low to intermediate affinity was mainly driven by an increase in the bimolecular association rate (*k*~on~) and the transition from intermediate to high affinity was mainly driven by lower *k*~off~ (slower release of bound ligand; [@B84]). Notably, the αI metal ion-dependent adhesion site (MIDAS) that recognizes ligand retains the same coordination and conformation in the putative αI low and intermediate affinity conformations. Therefore, in addition to the macromolecular integrin structures, it is apparent that the αI domain may exist in three distinct conformations regulated by the relative position of the α7 helix. There is ample evidence, as will be discussed below, that extended LFA-1 mediates neutrophil slow rolling by transiently binding to ICAM-1. During slow rolling, the α~L~ I domain is most likely not in the high affinity conformation.

In the "high affinity state" structure, swingout of the hybrid domain away from the α subunit by approximately 60° is coupled to opening of the headpiece through the downward movement of the αI domain α7 helix that connects to the βI domain as an internal ligand for the βI MIDAS ([@B7]; [@B97]; [@B59]). This shift in the α7 helix is coupled to rearrangement of the αI domain, enhancing its affinity for ligand ([@B7]; [@B102]). It is the high affinity LFA-1 conformer that mediates arrest of leukocytes on the endothelium ([@B24]; [@B32]), and *in vitro* studies demonstrate that the open headpiece of LFA-1 is necessary and sufficient to mediate cell arrest under flow conditions ([@B77], [@B78]).

The structure and affinity of integrin receptors is thought to be regulated by cells in an "inside-out" manner \[**Box [1](#BX1){ref-type="boxed-text"}**\] through signaling cascades that impinge upon the integrin cytoplasmic tails ([@B28]; [@B71]; [@B85]). Two intracellular protein families have been implicated in the final events of integrin activation. Talins and Kindlins both contain a band 4.1/ezrin/radixin/moesin (FERM) domain with four independently folded subdomains (F0--F3; [@B69]). While the FERM domain comprises the talin head that is sufficient for activating integrins ([@B16]; [@B103]), talins also have a flexible rod domain that contains actin-binding sequences and mediates cytoskeletal association ([@B25]). Although many of the structural and functional studies that have dissected the role of talin in integrin activation have employed experimental systems where the talin head domain alone is used, the full-length molecule exists in a basal autoinhibited state that is mediated by contact between the integrin-binding F3 subdomain and rod domain ([@B33]). Binding to phospholipids, such as phosphatidylinositol 4,5-bisphosphate (PIP~2~), relieves this autoinhibition and activates talin for integrin binding ([@B65]; [@B33]). The ability of talins and Kindlins to activate integrins depends on their binding to membrane phospholipids. For talin, this occurs through positively charged surfaces within the F1, F2, and F3 subdomains ([@B8]; [@B34]). Kindlins have an analogous surface within the F1 subdomain ([@B15]) as well as an additional pleckstrin homology domain that is inserted within its F2 subdomain ([@B93]; [@B74]), both of which bind to membrane phospholipids and are important for integrin activation.

Talins and Kindlins mediate integrin activation by binding directly to separate NXX(Y/F) motifs within the integrin β chain short cytoplasmic tail ([@B91]; [@B36]). Multiple lines of evidence demonstrate that talins contribute to the separation of the integrin TMDs ([@B43]; [@B96]), but the mechanisms by which Kindlins are involved in regulating integrin conformation are largely unknown ([@B69]; [@B82]). Mutations of Kindlin-3, the Kindlin isoform expressed in hematopoietic cells, were found to underlie the leukocyte adhesion deficiency type III (LAD-III) pathology ([@B63]; [@B68]; [@B90]) \[**Box [3](#BX3){ref-type="boxed-text"}**\]. Kindlin-3-deficient leukocytes are unable to arrest on inflamed endothelium, but their selectin-mediated rolling capacity is normal, indicating an important role for Kindlin-3 in LFA-1 activation ([@B68]). The roles of talin-1 and Kindlin-3 in regulating LFA-1 in neutrophils are discussed in further detail below.

###### Box 3 Leukocyte adhesion deficiency type III.

In the human disease leukocyte adhesion deficiency type III (LAD-III), activation of β~2~, β~3~, and some β~1~ integrins is defective. LAD-III was discovered in 1997 and initially called LAD-I variant ([@B48]). Kuijpers and colleagues recognized that expression of β~2~ integrins was normal but their activation was defective in these patients ([@B3]; [@B5]; [@B63]; [@B64]; [@B90]; [@B42]; [@B66]; [@B75]). Alon and colleagues ([@B73]) reported a point mutation in *RASGRP2*, the gene encoding CalDAG-GEFI, and thought that defective CalDAG-GEFI caused LAD-III. This idea was supported by the leukocyte and platelet adhesion deficiencies exhibited by CalDAG-GEFI knockout mice ([@B11]). However, it was later found that mutation of the *FERMT3* gene encoding Kindlin-3 that causes the pathology of LAD-III ([@B47]; [@B90]), dominates the phenotype of the subset of LAD-III patients with mutations in both *FERMT3* and *RASGRP2*. Humans deficient in CalDAG-GEFI, but not Kindlin-3, have not been described. There is now consensus that mutations in the *FERMT3* gene encoding kindlin-3 cause all known LAD-III cases ([@B1]).

MODELS OF LFA-1 ACTIVATION
==========================

There are several models of integrin activation by inside-out signaling. The dynamic equilibrium that exists between the various integrin conformational states (**Figure [1](#F1){ref-type="fig"}**) appears to vary between the 24 different integrin subtypes and even amongst the four different β~2~ integrins ([@B70]). Therefore, aside from the most basic structural commonalities, integrin activation mechanisms may exhibit significant variability.

The switchblade model of integrin activation stems from the delineation of the three distinct affinity states described above, and was formulated based on crystallography ([@B99]; [@B97]) and studies of isolated integrins by electron microscopy ([@B92]; [@B70]). The switchblade model postulates that only the closed, unliganded integrin headpiece can stably exist in the overall bent structure. The switchblade-like extension of the extracellular domain occurs as a result of disruption of headpiece-lower leg and α/β lower leg stabilizing contacts, either by separation of the TMDs or by ligand-induced hybrid domain swingout ([@B59]). The switchblade model received support from the recent finding that single, full-length α~IIb~β~3~ integrin embedded in membrane has the same compact structure observed in isolated extracellular domains and can undergo ectodomain extension in the presence of talin head domain bound to the integrin cytoplasmic tail ([@B103]). Most of the activated structures observed in this study, however, resembled the intermediate rather than the high affinity conformation. As discussed below, an important unresolved question is whether inside-out signaling alone (that is, in the absence of ligand binding) induces the high affinity structure with an open headpiece.

The deadbolt model of integrin activation was proposed ([@B100]) based on the observation that crystals of the unbound ([@B99]) and ligand-occupied ([@B101]) integrin α~V~β~3~ exhibited the same compact, bent structure. The crystal structure of ligand-occupied, bent α~V~β~3~ was further supported by electron microscopy studies ([@B2]). In addition, FRET studies have shown that small ligand binding to α~4~β~1~ integrin (VLA-4) on the living cell surface can occur in the absence of ectodomain extension ([@B23]). The deadbolt model posits that a loop within the β subunit extracellular membrane-proximal β-tail domain contacts the α7 helix of the βI domain that regulates its conformation and affinity ([@B100]). During activation, movement of the TMDs would disrupt the deadbolt and allow headpiece opening in the bent structure ([@B100]). However, elimination of the β-tail domain loop that was proposed to form the deadbolt did not enhance ligand binding ([@B108]).

More recent work suggests that inside-out integrin activation is more complicated than the switchblade and deadbolt models imply. For example, in kinetic studies of VLA-4 on live cells, binding of antibodies that recognize epitopes selectively exposed in extended integrin structures was minimal after triggering two different physiologic inside-out activation pathways, but was robust in the presence of a small ligand even without cell stimulation ([@B22]). The same group recently performed similar experiments with a fluorescent ligand probe of LFA-1 and found that small ligand binding to LFA-1 in the absence of inside-out activation was very slow ([@B21]). These findings indicate a greater restraint on inactive LFA-1 compared to VLA-4 with respect to ligand binding. Inside-out stimulation via chemokine or formyl peptide receptors \[both G-protein coupled receptors (GPCRs)\] rapidly enhanced LFA-1 small ligand binding, suggesting affinity upregulation of the headpiece. These studies suggest that mechanisms of integrin conformational regulation, including inside-out and ligand-induced outside-in activation, have both shared and distinct components between integrin subtypes and activating stimuli.

It is clear that inside-out signal transduction pathways, such as those elicited by chemokine receptor engagement, stimulate an increase in the affinity of integrins. The ability of LFA-1 to bind ICAM-1 in its soluble, rather than immobilized, form has been utilized as a sensitive assay that specifically reports the high affinity state ([@B24]; [@B83],[@B84]). Further support for this assay as a means to discriminate between extended/closed and extended/open conformations of LFA-1 was provided by Laudanna and colleagues ([@B14]) by showing that a signaling defect in headpiece opening due to silencing of phosphatidylinositol-4-phosphate 5-kinase type I gamma (PIP5KC) blocks chemokine-induced soluble ICAM-1 binding to T lymphocytes despite the ability of LFA-1 to become extended (as indicated by a reporter mAb) under the same conditions. Many studies have thus demonstrated that chemokines induce a high affinity state of LFA-1 that is competent for soluble ICAM-1 binding and that mediates T lymphocyte arrest ([@B24]; [@B32]; [@B14]).

Despite these extensive studies, it is not clear whether chemokine stimulation alone, in the absence of ligand, triggers opening of the LFA-1 headpiece. Chemokines induce the binding of epitope-specific reporter antibodies, such as mAb 24 ([@B27]) and 327C mAb ([@B10]), that specifically recognize the extended/open high affinity conformation of LFA-1 ([@B14]). However, these reporter antibodies also recognize ICAM-1-bound LFA-1 in the absence of cellular stimulation ([@B10]). Therefore, it remains possible that chemokines enhance the affinity of LFA-1 for ICAM-1 and permit a transition to the high affinity state, but do not directly induce opening of the headpiece associated with the high affinity αI domain. Rather, ligand engagement and a force pulling on the engaged integrin may subsequently be needed for LFA-1 to achieve its high affinity state. Affinity measurements of LFA-1 on the cell surface show that inside-out signaling in response to stromal cell-derived factor-1 (SDF-1, also known as chemokine CXCL12) or PMA, an activator of protein kinase C, enhanced binding of soluble monovalent ICAM-1, indicating affinity upregulation ([@B79]). However, artificially stabilizing specific LFA-1 structures resulted in ICAM-1 binding affinities of the intermediate affinity state that were similar to those achieved by inside-out activation, and of the high affinity state that were much higher. In a novel assay in which antibodies that specifically recognize extended LFA-1 conformers (KIM127 mAb and NKI-L16 mAb) or the putative high affinity state of LFA-1 (327C mAb) were co-immobilized with the chemokine CXCL12, it was found that peripheral blood lymphocytes bound only KIM127 and NKI-L16, but not 327C ([@B80]). These data all suggest that chemokines trigger LFA-1 extension, but cannot induce the full affinity of the ligand-binding headpiece.

If inside-out activation does not shift integrin affinity to its highest state, how then does ligand binding do so? The demonstration of a catch bond between LFA-1 and ICAM-1 provides insight into a possible mechanism and also suggests an important role for force in affinity maturation of the αI domain ([@B18]). Using a biomembrane probe to ligate single LFA-1 molecules and measure bond kinetics in the absence or presence of a pulling force, Zhu and colleagues ([@B18]) demonstrate that ICAM-1-occupied LFA-1 passes through three distinct bond lifetime regimes with increasing force. Pulling on the bond first enhanced LFA-1 affinity (catch bond) and then, for larger forces, resulted in a decrease in bond lifetime (slip bond). They propose that pulling on the αI domain results in its movement away from the βI domain, causing the anchored (to the βI MIDAS) α7 helix to experience a relative shift downward (as discussed above) and resulting in affinity upregulation of the αI domain ([@B18]). Thus, in the context of physiologic leukocyte--endothelial interactions in which LFA-1 bonds experience a force from blood flow acting on rolling or adherent cells, chemokines may stimulate LFA-1 extension while enhancing affinity of the headpiece only moderately. Upon ICAM-1 engagement, the bond would then undergo further affinity maturation and transition into the high affinity conformation supporting long-lived bonds. This model of force-mediated LFA-1 affinity maturation also suggests a role for cytoskeletal anchorage of the integrin tail ([@B4]; [@B109]). Talin represents the best candidate for mediating such actin linkage through sequences in its rod domain ([@B25]), though a specific role for talin-mediated actin filament association in LFA-1 activation is yet to be described. A potential role for Kindlins in mediating indirect cytoskeletal anchorage is also discussed below in further detail.

REGULATION OF LFA-1 ACTIVATION IN NEUTROPHILS
=============================================

Neutrophils play a central role in immunity as the first leukocyte subset to enter tissues in response to infection or injury. Inflammatory cues produced locally in the tissue are relayed to neutrophils through the expression of adhesion molecules, such as E-selectin and ICAM-1, on the luminal surface of endothelial cells. This induced expression of adhesion molecules initiates a cascade of progressive interactions between leukocytes and the vascular wall that precede transmigration across the endothelial barrier and into the affected tissue ([@B55]).

Members of the β~2~ integrin family \[**Box [2](#BX2){ref-type="boxed-text"}**\], whose expression is restricted to leukocytes and leukocyte-derived tissue cells, are involved at several steps of the leukocyte adhesion cascade. Initial capture and rolling of neutrophils is mediated primarily by endothelial E- and P-selectins binding to P-selectin glycoprotein ligand-1 (PSGL-1) and other selectin ligands on the surface of neutrophils. In addition to its function as an adhesion receptor, PSGL-1 transduces an intracellular signal that partially activates LFA-1 ([@B105]; [@B67]; [@B49]; **Figure [2](#F2){ref-type="fig"}**). Although other leukocyte subsets, including some memory T lymphocytes, express functional PSGL-1, it seems that ligation of PSGL-1 triggers LFA-1 extension only in myeloid cells. It may be that the lymphoid homologs of one or more molecules downstream of PSGL-1 do not participate in this signaling pathway ([@B6]). The molecular details of the signal transduction pathway triggered by PSGL-1 engagement and leading to LFA-1 activation in neutrophils has been the subject of recent reviews ([@B107], [@B106]), and new details on this signaling cascade continue to emerge ([@B89]; [@B13]; [@B51]; [@B81]; [@B88]). During neutrophil rolling interactions with P- and E-selectin, PSGL-1 signaling results in the conversion of LFA-1 from an inactive state to an extended conformation that then interacts with ICAM-1 to reduce neutrophil rolling velocity ([@B19]; [@B105]; [@B49]). Two main pieces of evidence demonstrate that the extended LFA-1 conformer with a closed headpiece mediates slow rolling in both murine and human neutrophils. First, an LFA-1 allosteric antagonist that binds to the βI domain and blocks structural communication with the αI domain, thus preventing headpiece opening, completely abrogates soluble ICAM-1 binding ([@B83]) and neutrophil arrest, but does not impair LFA-1-dependent slow rolling ([@B105]). Second, the KIM127 mAb ([@B76]) and NKI-L16 mAb ([@B94]) epitopes that report extension of the β~2~ and α~L~ legs, respectively, are exposed in human neutrophils rolling on E-selectin in flow chambers ([@B49]). In the same assay, the mAb 24 ([@B27]) recognition site that is only accessible in the high affinity state remains buried unless neutrophils are activated by Mn^2+^ ([@B49]). Thus, ligation of PSGL-1 induces LFA-1 extension, but not (full) opening of the headpiece.

![**Neutrophil inside-out activation of LFA-1.** Two distinct signal transduction pathways modulate LFA-1 activation in neutrophils: (1) selectin binding to PSGL-1, and (2) chemokine receptor engagement. PSGL-1 signals talin-1-dependent LFA-1 extension, whereas chemokine GPCRs signal LFA-1 activation to a high affinity state that requires both talin-1 and Kindlin-3. Some of these signaling molecules may exist in preformed modules to facilitate rapid integrin activation. Abbreviations: Fgr, feline Gardner--Rasheed sarcoma kinase; FcRγ, immunoglobulin gamma Fc receptor; DAP12, DNAX activating protein of 12 kDa; Syk, spleen tyrosine kinase; ADAP, adhesion and degranulation promoting adaptor protein; SLP-76, SH2 domain-containing leukocyte phosphoprotein of 76 kDa; Btk, Bruton tyrosine kinase; PI3K, phosphoinositide 3-kinase; PLC, phospholipase C; p38, p38 mitogen activated protein kinase; IP~3~, inositol trisphosphate; DAG, diacylglycerol; CalDAG-GEFI, calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I; PSGL-1, P-selectin glycoprotein ligand-1; ICAM-1, intercellular adhesion molecule-1; GAG, glycosaminoglycan.](fimmu-03-00157-g002){#F2}

During inflammation, neutrophils encounter immobilized chemokines as they roll on the vascular wall. LFA-1 is the primary integrin receptor involved in leukocyte arrest on inflamed endothelium, with little or no detectable contribution of Mac-1 ([@B26]; [@B55]). SDF-1α (a ligand for CXCR4) and chemokine ligands for CXCR2 trigger soluble ICAM-1 binding and rapid lymphocyte arrest on immobilized ICAM-1 ([@B24]; [@B32]; [@B80]; [@B14]). This has been interpreted to mean that high affinity LFA-1 is required to mediate leukocyte arrest. Intravital microscopy analysis of the mouse cremaster muscle, a thin tissue that envelops the testes, after intravenous injection of CXCL1 provides a sensitive arrest assay, as neutrophils rapidly (within 15 s) transition from rolling to arrest on the endothelium. This assay provides the ability to distinguish the arrest step from adhesion stabilization, as neutrophils lacking signaling molecules involved in the latter process, such as PI3Kγ ([@B86]) and PKCθ ([@B12]), quickly detach and return to the bulk flow. Since chemokine signaling also contributes to the stabilization and strengthening of leukocyte adhesion following arrest by enhancing LFA-1 mobility and allowing clustering to occur ([@B24]; [@B32], [@B31]), the analysis of rapid arrest *in vivo* is critical for assessing the functional role of molecules in inside-out activation of LFA-1. CXCL1 (also known as keratinocyte-derived chemokine) is the primary chemokine involved in murine neutrophil arrest through CXCR2 and activation of the Gα~i2~ signaling cascade ([@B54]; [@B87]; [@B104]). In the context of inflammation, both the PSGL-1 and CXCR2 signaling pathways that regulate LFA-1 activation contribute to neutrophil adhesion and recruitment ([@B87]; [@B105]). PSGL-1 signaling seems to induce only the extended conformation of LFA-1, and even pulling on LFA-1 as it transiently engages with ICAM-1 in slow rolling is not sufficient to induce rapid neutrophil arrest mediated by the high affinity conformation. By contrast, in the presence of chemokines, neutrophil LFA-1 reaches its high affinity state and mediates arrest. Another potential difference between these two signaling pathways is that chemokine receptors trigger rapid and locally restricted LFA-1 activation ([@B80]), whereas PSGL-1 signals to LFA-1 may not be as spatially confined ([@B6]; [@B49]). It has been proposed that the downstream signaling proteins involved in integrin activation may be pre-assembled into complexes, thus allowing for leukocyte arrest to occur on the timescales observed experimentally ([@B6]). Consistent with this idea, a signaling module containing SKAP55 (Src kinase-associated phosphoprotein of 55 kDa), ADAP (adhesion and degranulation promoting adaptor protein), RIAM (Rap1-interacting adaptor molecule), and Kindlin-3 exists constitutively in unstimulated human T lymphocytes, and inducibly associates with the common integrin activator Rap1 GTPase ([@B45]).

NEW MECHANISTIC INSIGHTS INTO INSIDE-OUT LFA-1 ACTIVATION
=========================================================

LFA-1 has been a model for studying integrin activation for more than 20 years. The role of inside-out signaling in regulating LFA-1 structure and affinity is a topic of great interest not only in the fields of immunology and leukocyte adhesion, but also among integrin biologists. Until recently, the roles of two families of common integrin co-activators, talins and Kindlins, in regulating LFA-1 conformational activation had not been studied. Using mixed chimeric mice with genetic deletion of either *Fermt3* encoding Kindlin-3 or *Tln1* encoding talin-1, we tested the individual roles of these two proteins in neutrophil slow rolling and arrest mediated by LFA-1 ([@B51]). We reasoned that since different conformations of LFA-1 are induced by stimulating either the PSGL-1 or CXCR2 signaling cascades, it would be possible to separately test whether talin-1 and Kindlin-3 were involved in LFA-1 extension versus headpiece opening. We observed that LFA-1-dependent neutrophil slow rolling on E-selectin/ICAM-1 substrates in flow chambers and on inflamed endothelium *in vivo* was impaired in talin-1-deficient neutrophils, but was unaffected by knockout of Kindlin-3. In contrast, both talin-1 and Kindlin-3 were required for CXCL1-stimulated rapid neutrophil arrest and soluble ICAM-1 binding to LFA-1, indicating an important role for these co-activators in reaching the high affinity state of LFA-1. Our findings in neutrophils were corroborated by studies measuring LFA-1 affinity states using the reporter antibodies KIM127 ([@B76]), NKI-L16 ([@B94]), mAb 24 ([@B27]), and 2E8 ([@B17]) in human HL-60 cells stimulated with an active Rap1a peptide. Together, these results show that talin-1 is needed for LFA-1 extension, while Kindlin-3 is involved in transition of the LFA-1 headpiece to its high affinity state. These data are the first to demonstrate distinct functions of talin-1 and Kindlin-3 in inducing specific conformers of LFA-1. It remains to be shown whether talin-1 plays an additional role in LFA-1 headpiece opening to reach the high affinity state, or whether LFA-1 extension is a prerequisite for headpiece opening in the context of chemokine-induced neutrophil arrest. Furthermore, previous studies of cultured effector T lymphocytes derived from LAD-III patients suggest that Kindlin-3 is needed for LFA-1 extension in the context of chemokine stimulation ([@B64]). It is apparent that there are diverse mechanisms among the various modalities of integrin activation in leukocytes.

What do these new insights into talin-1 and Kindlin-3 regulation of LFA-1 structure tell us about the mechanisms of inside-out activation? It was not surprising to find that talin-1 is needed for LFA-1 extension. As shown for α~IIb~β~3~ in a reconstituted system, the talin head domain (but not intact, autoinhibited talin) is sufficient to induce extension of the integrin extracellular domain ([@B103]). Several studies have shown that talin directly disrupts the basal association of integrin TMDs by contacting the salt bridge between the α and β chains close to the inner membrane leaflet ([@B96]; [@B8]). Talin is likely involved in further rearrangement of the TMDs, as mutations that disrupt the α/β salt bridge do not fully overcome the requirement for talin in integrin activation ([@B91]; [@B96]). That Kindlin-3 was not required for neutrophil slow rolling mediated by the extended/closed conformer of LFA-1 ([@B51]) suggests that it may not be involved in initial disruption of the LFA-1 TMDs. However, structural studies of LFA-1 suggest that the TMDs and lower legs are separated even further in high affinity than in intermediate affinity LFA-1 ([@B70]). Thus, Kindlin-3 may be involved in inducing swingout of the hybrid domain by causing a further separation of the TMDs. It is also possible that Kindlin-3 mediates the indirect linkage of the β~2~ integrin tail to the actin cytoskeleton through a scaffolding function, thus providing an anchor for force-induced conversion of ligated integrins to the high affinity state. It was recently found that LFA-1-mediated neutrophil slow rolling is not dependent on the linkage of LFA-1 to the actin cytoskeleton ([@B81]), but chemokine-stimulated arrest of lymphocytes ([@B80]) and neutrophils ([@B81]) is impaired by reagents that disrupt actin microfilaments. These studies support the idea that LFA-1 extension and headpiece opening are distinctly regulated processes, and that Kindlin-3 may be involved in the transition to a high affinity state through an indirect interaction with the actin cytoskeleton. Kindlins have been shown to bind to several actin-binding proteins and complexes, including integrin-linked kinase ([@B62]), migfilin ([@B93]), focal adhesion kinase, and α-actinin ([@B37]). The expression and role of these adaptor molecules in LFA-1 activation will need to be tested in leukocyte arrest under flow conditions.

The distinct roles of talin-1 and Kindlin-3 in neutrophil slow rolling and arrest raise several questions about the two signaling pathways that stimulate these separate behaviors. Clearly, LFA-1 engages ICAM-1 during slow rolling interactions induced by PSGL-1 signaling. If chemokines directly stimulate only LFA-1 extension and not conversion to the high affinity state, why does CXCR2 engagement lead to neutrophil behavior qualitatively distinct from the PSGL-1 pathway that has also been shown to induce LFA-1 extension? Likewise, if force on the LFA-1/ICAM-1 bond results in affinity maturation to the long-lived state, how are neutrophils able to use LFA-1 for rolling interactions that require a transient bond with a fast off-rate? Structural communication between the βI and αI domains through the α7 helix is needed for headpiece opening ([@B83]). Perhaps Kindlin-3 provides a permissive signal or induces a structural rearrangement that allows coupling of the βI and αI domains, such as swingout of the hybrid domain. We speculate that Kindlin-3 may be actively excluded from binding to the β~2~ cytoplasmic tail after inside-out activation of LFA-1 by the PSGL-1 signaling pathway and this prevents the transition to the open headpiece and neutrophil arrest. This could occur by promoting the binding of a competing molecule to the Kindlin-3 binding NPKF site on the β~2~ tail, or by regulating phosphorylation of threonine residues that also contribute to Kindlin-3 binding ([@B61]). Indeed, T cell receptor signaling affects the phosphorylation of β~2~T758 and promotes binding of 14-3-3 proteins and LFA-1 activation ([@B30]; [@B35]). Whether this is also true for chemokine signaling is unknown.

A potential alternative mechanism for LFA-1 extension resulting in distinct slow rolling and arrest behaviors after PSGL-1 and CXCR2 signaling, respectively, may be that chemokines also stimulate an increase in LFA-1 mobility in the membrane ([@B24]) that could lead to ligand-driven LFA-1 clustering and subsequent firm adhesion. This mechanism would require that LFA-1 ligands like ICAM-1 are pre-clustered on endothelial cells ([@B9]), because integrin clustering is most likely a post-ligand binding event ([@B44]). In the case of slow rolling, if LFA-1 is immobile following PSGL-1 engagement then clustering may be disfavored and the force on individual LFA-1/ICAM-1 bonds could be sufficiently high so that LFA-1 resides in the slip bond regime with short enough lifetimes (high *k~off~*) to support rolling behavior. Clearly, much remains to be tested to uncover the mechanisms regulating LFA-1 structure and affinity on the surface of leukocytes.

CONCLUDING REMARKS
==================

LFA-1 plays important roles in the trafficking of multiple leukocyte subsets during the immune response. At least two distinct signaling pathways impact the adhesive function of LFA-1 by altering its structure, and thus affinity for extracellular ligands. Post-ligand binding LFA-1 clustering alters its distribution on the plasma membrane. Our understanding of how cellular factors regulate LFA-1 conformation by binding to its short cytoplasmic tails has evolved as Kindlin-3 and talin-1 have been identified as major and distinct players. The concepts explaining how structural rearrangements are propagated through the TMDs and integrin legs to the ligand-binding headpiece are being refined. It has recently become clear that force plays an integral role in these processes, and future work will be aimed at determining the molecular requirements and mechanisms of LFA-1 affinity regulation by force in rolling and arresting leukocytes.
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